CLOV vs LGN
Clover Health Investments Corp (CLOV) versus Legence Corp. Class A Common stock (LGN) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Legence Corp. Class A Common stock (LGN) is a engineering & construction company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported LGN revenue for 2025-09-30 was $708.0M. Net income was $379.0K. Revenue was up 26.2% from 2024-09-30 to 2025-09-30. LGN currently screens at market cap $14.66B.
CLOV currently screens at market cap $1.55B. LGN currently screens at market cap $14.66B.
Not investment advice. Open the CLOV and LGN stock pages for the full models.
Not investment advice.